ArticleNature immunology2024
ZBTB46 coordinates angiogenesis and immunity to control tumor outcome.
Abstract read
In one paragraph
Article in Nature immunology, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 15 papers.
0numbers the graph read from it
0cells of the map it votes in
15citing papers in PubMed
–field-weighted citation impact
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
15 citing papers in PubMed.
- Article
- Dissecting the aberrant vasculature of glioblastoma: mechanisms and therapeutic targets.Cancer metastasis reviews · 2026Review
- Endothelial PDLIM5 promotes tip cell filopodia formation and tumor angiogenesis by regulating ACTN1/ACTN4-dependent actin bundling.Nature communications · 2026Article
- Cannabidiol suppresses emergency MDSCs generation by disturbing EEF1B2-mediated C/EBPJournal for immunotherapy of cancer · 2026Article
- Linking tumour angiogenesis and tumour immunity.Nature reviews. Immunology · 2026Review
- Harnessing the immune system: future directions in cancer immunotherapy.Frontiers in immunology · 2026Review
- Rewiring tumor immunity via zinc finger proteins: a new frontier in cancer immunotherapy.Journal of translational medicine · 2025Review
- NO-Driven Janus Nanomotor Enhances T-Cell Infiltration by Reconstructing Tumor-Associated Blood and Lymphatic Vessels.Advanced science (Weinheim, Baden-Wurttemberg, Germany) · 2025Article
- SMYD3 Promotes Immune Evasion in Clear Cell Renal Cell Carcinoma via SREBP1-Mediated Transactivation of CD47.Advanced science (Weinheim, Baden-Wurttemberg, Germany) · 2025Article
- Peptides: potential delivery systems for mRNA.RSC chemical biology · 2025Review
- Mesenchymal stem cell exosomes therapy for the treatment of traumatic brain injury: mechanism, progress, challenges and prospects.Journal of translational medicine · 2025Review
- EGR3 as a dual tumor-immune regulator: a machine learning-driven prognostic target for cold breast cancer.Frontiers in immunology · 2025Article
- Igniting Cold Tumors: Multi-Omics-Driven Strategies to Overcome Immune Evasion and Restore Immune Surveillance.Oncology research · 2025Review
- MCRS1 sensitizes T cell-dependent immunotherapy by augmenting MHC-I expression in solid tumors.The Journal of experimental medicine · 2024Article
- High-throughput characterization of functional variants highlights heterogeneity and polygenicity underlying lung cancer susceptibility.American journal of human genetics · 2024Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
13 authors.
Ashraf Ul KabirDepartment of Pathology and Immunology, Washington University School of Medicine, St. Louis, MO, USA.ORCID http://orcid.org/0000-0002-9449-8238
Carisa ZengDepartment of Pathology and Immunology, Washington University School of Medicine, St. Louis, MO, USA.ORCID http://orcid.org/0000-0002-7108-3873
Madhav SubramanianDepartment of Pathology and Immunology, Washington University School of Medicine, St. Louis, MO, USA.ORCID http://orcid.org/0000-0002-1957-4982
Jun WuDepartment of Pathology and Immunology, Washington University School of Medicine, St. Louis, MO, USA.
Minseo KimDepartment of Pathology and Immunology, Washington University School of Medicine, St. Louis, MO, USA.
Karen KrchmaDepartment of Pathology and Immunology, Washington University School of Medicine, St. Louis, MO, USA.
Xiaoli WangDepartment of Pathology and Immunology, Washington University School of Medicine, St. Louis, MO, USA.
Carmen M HalabiDepartment of Pediatrics, Washington University School of Medicine, St. Louis, MO, USA.ORCID http://orcid.org/0000-0003-4889-8131
Hua PanDepartment of Medicine, Washington University School of Medicine, St. Louis, MO, USA.
Samuel A WicklineHealth Heart Institute, Morsani College of Medicine, University of South Florida, Tampa, FL, USA.
Daved H FremontDepartment of Pathology and Immunology, Washington University School of Medicine, St. Louis, MO, USA.ORCID http://orcid.org/0000-0002-8544-2689
Maxim N ArtyomovDepartment of Pathology and Immunology, Washington University School of Medicine, St. Louis, MO, USA.ORCID http://orcid.org/0000-0002-1133-4212
Kyunghee ChoiDepartment of Pathology and Immunology, Washington University School of Medicine, St. Louis, MO, USA. kchoi@wustl.edu.ORCID http://orcid.org/0000-0002-9634-9375
Funding
Washington University Center for Cellular ImagingP30CA091842 · NCI · WASHINGTON UNIVERSITY · PI TIMOTHY J. EBERLEIN · 2001 to 2026
$128.0MHemangioglast Development and RegulationR01HL055337 · NHLBI · WASHINGTON UNIVERSITY · PI CHOI, KYUNGHEE · 2001 to 2024
$9.1MMyct1 control of the angioimmune interfaceR01CA271714 · NCI · WASHINGTON UNIVERSITY · PI KYUNGHEE CHOI, Changwon Park · 2023 to 2026
$2.2MEpigenetic regulations of macrophage developmentR01HL149954 · NHLBI · WASHINGTON UNIVERSITY · PI CHOI, KYUNGHEE · 2020 to 2023
$2.1MNCI NIH HHS P30 CA091842NCI NIH HHS R01 CA271714NHLBI NIH HHS R01 HL055337NHLBI NIH HHS R01 HL149954U.S. Department of Health & Human Services | NIH | National Cancer Institute (NCI) R01CA271714U.S. Department of Health & Human Services | NIH | National Heart, Lung, and Blood Institute (NHLBI) R01HL149954U.S. Department of Health & Human Services | NIH | National Heart, Lung, and Blood Institute (NHLBI) R01HL55337
Abstract
Tumor angiogenesis and immunity show an inverse correlation in cancer progression and outcome
Indexed as
Dendritic CellsNeovascularization, PathologicTumor MicroenvironmentAngiogenesisAnimalsCCAAT-Enhancer-Binding Protein-betaCell Line, TumorEndothelial CellsFemaleGene Expression Regulation, NeoplasticHumansMiceMice, Inbred C57BLMice, KnockoutNeoplasmsRepressor ProteinsCCAAT-Enhancer-Binding Protein-betaRepressor ProteinsTranscription FactorsZbtb46 protein, mouse
Identifiers
What OpenQuestion holds
Textmetadata
LicenceTDM
Read underepoch 390
Registered trials
None linked
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.